Literature DB >> 15709746

In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.

Ilia V Baskakov1, Olga V Bocharova.   

Abstract

The "protein only" hypothesis of prion propagation postulates that the abnormal isoform of the prion protein, PrP(Sc), acts as a causative and transmissible agent of prion disease. In attempt to reconstitute prion infectivity in vitro, we previously developed a cell-free conversion protocol for generating amyloid fibrils from a recombinant prion protein encompassing residues 89-231 (rPrP 89-230) [Baskakov et al. (2002) J. Biol. Chem. 277, 21140]. When inoculated into transgenic mice, these amyloid fibrils induced prion disease, which can be efficiently transmitted to both wild-type and transgenic mice [Legname et al. (2004) Science 305, 673]. Here we show that the polymerization of rPrPs into the fibrils displays a number of distinctive kinetic features that are not typical for polymerization by other amyloidogenic polypeptides. Specifically, the lag phase of polymerization showed only modest dependence on protein concentration, and the conversion reaction displayed a dramatic volume-dependent threshold effect. To explain these unique kinetic features, we proposed that the conversion reaction is regulated by the dynamics between the rates of multiplication and deactivation of self-propagating fibrillar isoforms. Our further studies demonstrated that surface-dependent sorption of fibrillar isoforms is responsible for their deactivation in vitro, while fibril fragmentation seems to account for the multiplication of the active centers of polymerization. Our findings support the hypothesis that development of prion disease is controlled by a fine dynamic balance between self-propagation and clearance/deactivation of PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709746     DOI: 10.1021/bi048322t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

3.  A generic crystallization-like model that describes the kinetics of amyloid fibril formation.

Authors:  Rosa Crespo; Fernando A Rocha; Ana M Damas; Pedro M Martins
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

4.  Complement protein C1q forms a complex with cytotoxic prion protein oligomers.

Authors:  Paul Erlich; Chantal Dumestre-Pérard; Wai Li Ling; Catherine Lemaire-Vieille; Guy Schoehn; Gérard J Arlaud; Nicole M Thielens; Jean Gagnon; Jean-Yves Cesbron
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

5.  Influence of the N-terminal domain on the aggregation properties of the prion protein.

Authors:  Kristen N Frankenfield; Evan T Powers; Jeffery W Kelly
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

6.  The dominant-negative effect of the Q218K variant of the prion protein does not require protein X.

Authors:  Cheng I Lee; Qingyuan Yang; Veronique Perrier; Ilia V Baskakov
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

7.  Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size.

Authors:  Ying Sun; Natallia Makarava; Cheng-I Lee; Pongpan Laksanalamai; Frank T Robb; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-01-03       Impact factor: 5.469

8.  Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding.

Authors:  Zheng Zhou; Jun-Bao Fan; Hai-Li Zhu; Frank Shewmaker; Xu Yan; Xi Chen; Jie Chen; Geng-Fu Xiao; Lin Guo; Yi Liang
Journal:  J Biol Chem       Date:  2009-09-10       Impact factor: 5.157

9.  Purification and Fibrillation of Full-Length Recombinant PrP.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2017

10.  Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins.

Authors:  Jihoon Kim; Masaki Kobayashi; Makoto Fukuda; Daisuke Ogasawara; Natsuki Kobayashi; Sungwoong Han; Chikashi Nakamura; Masaki Inada; Chisato Miyaura; Kazunori Ikebukuro; Koji Sode
Journal:  Prion       Date:  2010-01-04       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.